Marc N.  Casper net worth and biography

Marc Casper Biography and Net Worth

Marc N. Casper serves as Chairman of the Board, President, Chief Executive Officer of the Company. As the only member of the Company’s management to serve on the Board, Mr. Casper contributes a deep and valuable understanding of Thermo Fisher history and day-to-day operations. This contribution is stemmed further from Mr. Casper’s 20-plus years in the life sciences and healthcare equipment industry, and his long standing employment with the Company. Additionally, Mr. Casper’s experience as the Chief Executive Officer of the Company, and previously serving in various senior level management roles, enables him to provide strategic leadership skills and financial acumen and expertise that are invaluable to the Board.

What is Marc N. Casper's net worth?

The estimated net worth of Marc N. Casper is at least $24.62 million as of February 15th, 2024. Mr. Casper owns 43,608 shares of Thermo Fisher Scientific stock worth more than $24,623,257 as of February 23rd. This net worth approximation does not reflect any other investments that Mr. Casper may own. Additionally, Mr. Casper receives an annual salary of $8,010,000.00 as CEO at Thermo Fisher Scientific. Learn More about Marc N. Casper's net worth.

How old is Marc N. Casper?

Mr. Casper is currently 56 years old. There are 5 older executives and no younger executives at Thermo Fisher Scientific. Learn More on Marc N. Casper's age.

What is Marc N. Casper's salary?

As the CEO of Thermo Fisher Scientific Inc., Mr. Casper earns $8,010,000.00 per year. Learn More on Marc N. Casper's salary.

How do I contact Marc N. Casper?

The corporate mailing address for Mr. Casper and other Thermo Fisher Scientific executives is 168 Third Avenue, Waltham MA, 02451. Thermo Fisher Scientific can also be reached via phone at (781) 622-1000 and via email at [email protected]. Learn More on Marc N. Casper's contact information.

Has Marc N. Casper been buying or selling shares of Thermo Fisher Scientific?

In the last ninety days, Marc N. Casper has sold $8,610,589.14 of Thermo Fisher Scientific stock. Most recently, Marc N. Casper sold 5,547 shares of the business's stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $550.62, for a transaction totalling $3,054,289.14. Following the completion of the sale, the chief executive officer now directly owns 43,608 shares of the company's stock, valued at $24,011,436.96. Learn More on Marc N. Casper's trading history.

Who are Thermo Fisher Scientific's active insiders?

Thermo Fisher Scientific's insider roster includes Michael Boxer (SVP), Marc Casper (CEO), Peter Hornstra (CAO), Syed Jafry (VP), Michel Lagarde (EVP), Jim Manzi (Director), Gianluca Pettiti (EVP), Debora Spar (Director), Mark Stevenson (COO), and Stephen Williamson (CFO). Learn More on Thermo Fisher Scientific's active insiders.

Are insiders buying or selling shares of Thermo Fisher Scientific?

During the last twelve months, Thermo Fisher Scientific insiders bought shares 1 times. They purchased a total of 4 shares worth more than $2,104.60. During the last twelve months, insiders at the medical research company sold shares 13 times. They sold a total of 98,077 shares worth more than $52,182,841.22. The most recent insider tranaction occured on February, 15th when CEO Marc N Casper sold 5,547 shares worth more than $3,054,289.14. Insiders at Thermo Fisher Scientific own 0.3% of the company. Learn More about insider trades at Thermo Fisher Scientific.

Information on this page was last updated on 2/15/2024.

Marc N. Casper Insider Trading History at Thermo Fisher Scientific

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/15/2024Sell5,547$550.62$3,054,289.1443,608View SEC Filing Icon  
2/7/2024Sell10,000$555.63$5,556,300.0049,155View SEC Filing Icon  
11/6/2023Sell10,000$454.41$4,544,100.00131,175View SEC Filing Icon  
11/3/2023Sell10,000$456.15$4,561,500.00131,175View SEC Filing Icon  
8/8/2023Sell1,600$550.60$880,960.00135,330View SEC Filing Icon  
8/3/2023Sell10,000$549.00$5,490,000.00141,330View SEC Filing Icon  
5/9/2023Sell1,600$534.82$855,712.00141,330View SEC Filing Icon  
5/5/2023Sell10,000$545.22$5,452,200.00141,330View SEC Filing Icon  
3/13/2023Sell7,500$544.49$4,083,675.0066,655View SEC Filing Icon  
2/14/2023Sell1,600$571.96$915,136.00128,705View SEC Filing Icon  
2/10/2023Sell20,000$569.18$11,383,600.00128,705View SEC Filing Icon  
11/7/2022Sell8,100$493.16$3,994,596.00178,005View SEC Filing Icon  
11/3/2022Sell8,200$487.45$3,997,090.00178,005View SEC Filing Icon  
10/31/2022Sell10,000$509.97$5,099,700.00178,005View SEC Filing Icon  
8/4/2022Sell10,000$589.76$5,897,600.00183,373View SEC Filing Icon  
8/2/2022Sell10,000$588.36$5,883,600.00183,373View SEC Filing Icon  
5/4/2022Sell2,181$562.46$1,226,725.26183,373View SEC Filing Icon  
5/2/2022Sell10,000$545.60$5,456,000.00183,373View SEC Filing Icon  
8/4/2021Sell10,000$539.05$5,390,500.00View SEC Filing Icon  
10/26/2020Sell10,000$479.94$4,799,400.00228,694View SEC Filing Icon  
7/31/2020Sell20,000$409.02$8,180,400.00260,446View SEC Filing Icon  
7/29/2020Sell20,000$411.05$8,221,000.00260,446View SEC Filing Icon  
7/27/2020Sell20,000$404.40$8,088,000.00260,446View SEC Filing Icon  
7/24/2020Sell20,000$403.37$8,067,400.00260,446View SEC Filing Icon  
6/1/2020Sell20,000$349.89$6,997,800.00294,946View SEC Filing Icon  
5/29/2020Sell20,000$349.26$6,985,200.00294,946View SEC Filing Icon  
4/28/2020Sell30,000$333.02$9,990,600.00304,946View SEC Filing Icon  
10/25/2019Sell47,729$295.88$14,122,056.52328,960View SEC Filing Icon  
9/13/2019Sell2,271$298.00$676,758.00283,502View SEC Filing Icon  
7/30/2019Sell50,000$284.83$14,241,500.00342,193View SEC Filing Icon  
4/30/2019Sell50,713$273.21$13,855,298.73302,193View SEC Filing Icon  
10/1/2018Sell125,520$247.50$31,066,200.00View SEC Filing Icon  
8/6/2018Sell50,000$233.95$11,697,500.00320,122View SEC Filing Icon  
6/15/2018Sell45,000$214.80$9,666,000.00315,122View SEC Filing Icon  
6/13/2018Sell50,000$217.71$10,885,500.00272,122View SEC Filing Icon  
3/22/2018Sell40,000$210.16$8,406,400.00334,622View SEC Filing Icon  
12/15/2017Sell50,000$191.74$9,587,000.00302,577View SEC Filing Icon  
11/15/2017Sell50,000$188.39$9,419,500.00252,577View SEC Filing Icon  
6/1/2017Sell20,000$172.79$3,455,800.00269,279View SEC Filing Icon  
3/15/2017Sell20,000$158.60$3,172,000.00289,279View SEC Filing Icon  
9/2/2016Sell28,797$151.01$4,348,634.97307,444View SEC Filing Icon  
9/1/2016Sell30,000$151.17$4,535,100.00308,647View SEC Filing Icon  
7/5/2016Sell20,000$147.69$2,953,800.00340,998View SEC Filing Icon  
7/1/2016Sell30,000$148.85$4,465,500.00350,998View SEC Filing Icon  
3/14/2016Sell30,000$139.28$4,178,400.00350,998View SEC Filing Icon  
9/17/2015Sell25,000$130.00$3,250,000.00360,607View SEC Filing Icon  
4/1/2015Sell20,000$131.89$2,637,800.00View SEC Filing Icon  
6/17/2013Sell43,396$85.58$3,713,829.68View SEC Filing Icon  
11/1/2012Sell125,000$62.49$7,811,250.00View SEC Filing Icon  
See Full Table

Marc N. Casper Buying and Selling Activity at Thermo Fisher Scientific

This chart shows Marc N Casper's buying and selling at Thermo Fisher Scientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Thermo Fisher Scientific Company Overview

Thermo Fisher Scientific logo
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $564.71
Low: $560.86
High: $566.68

50 Day Range

MA: $543.11
Low: $518.80
High: $566.94

2 Week Range

Now: $564.71
Low: $415.60
High: $593.17

Volume

966,781 shs

Average Volume

1,770,423 shs

Market Capitalization

$218.19 billion

P/E Ratio

36.55

Dividend Yield

0.25%

Beta

0.8